JUN 15, 2015 11:52 AM PDT

Spicy Solution to Curb Colorectal Cancer

WRITTEN BY: Ilene Schneider
The best way to keep an aggressive disease at bay may be on your spice rack, not in your medicine cabinet. You probably would be happy to have a sticky bun a day to ward off colon cancer too.
Compound in cinnamon may provide resistance to colorectal cancer.
Researchers from the University of Arizona (UA) College of Pharmacy Department of Pharmacology and Toxicity and the UA Cancer Center believe that "a compound derived from cinnamon is a potent inhibitor of colorectal cancer," according to an article in Cancer Prevention Research and reported in Science Daily (http://www.sciencedaily.com/releases/2015/06/150615094439.htm).

Georg Wondrak, Ph.D., associate professor, and Donna Zhang, Ph.D., professor, who are affiliated with both institutions, have completed a study proving that the addition of cinnamaldehyde, the chemical compound that gives cinnamon its flavor and aroma, to the diet of mice protected the mice against colorectal cancer. When they were fed cinnamaldehyde, the "animals' cells had acquired the ability to protect themselves against exposure to a carcinogen through detoxification and repair," the article said.

According to Zhang, there is "an urgent need to develop more effective strategies" against colorectal cancer, which can be aggressive and difficult to control if not diagnosed early. Wondrak, who said that cinnamon is the third-most-consumed spice in the world, was eager to explore its health benefits, something that has not been done. Interestingly, colorectal cancer is the third-most-common cancer in the United States.

Colorectal cancer, or colon cancer, which occurs in the colon or rectum, when discovered early, is highly treatable, according to the Colorectal Cancer Alliance website, which adds. "Even if it spreads into nearby lymph nodes, surgical treatment followed by chemotherapy is highly successful. In the most difficult cases - when the cancer has metastasized to the liver, lungs or other sites - treatment can prolong and add to one's quality of life. Most colon cancers develop first as colorectal polyps, which are abnormal growths inside the colon or rectum that may later become cancerous." The American Cancer Society estimated that 136,830 people would be diagnosed in 2014 and 50,310 would succumb to colon cancer in the United States. Risk factors include being over 50, having polyps, having a family history of colon cancer and having genetic alterations (http://www.ccalliance.org/colorectal_cancer/overview.html).

The study, 'Nrf2-dependent suppression of azoxymethane/dextrane sulfate sodium-induced colon carcinogenesis by the cinnamon-derived dietary factor cinnamaldehyde,' has been published online. Now the researchers want to determine whether cinnamon, as differentiated from cinnamaldehyde, can prevent colorectal cancer as well as other diseases, such as inflammatory dysregulation and diabetes. Because cinnamon is considered safe, a human clinical trial could be relatively easy to obtain.
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
JAN 02, 2020
Genetics & Genomics
JAN 02, 2020
Mysterious Extrachromosomal DNA is Linked to Childhood Cancer
Scientists are learning more about an unusual kind of DNA that's separate from a cell's genomic DNA....
JAN 21, 2020
Drug Discovery & Development
JAN 21, 2020
Drug Targets Gastrointestinal Cancer
The FDA has recently approved Ayvakit (avapritinib) for the treatment of unresectable and metastatic gastrointestinal stromal tumor (GIST) that occurs most...
FEB 02, 2020
Cancer
FEB 02, 2020
These cosmetics damage breast cells' DNA
A new approach to studying the effects of two common chemicals used in cosmetics and sunscreens found they can cause DNA damage in breast cells at surprisi...
FEB 11, 2020
Cancer
FEB 11, 2020
Could we be over-diagnosing cancer?
Roughly one in every two people are estimated to receive a cancer diagnosis at some point in their lives, but are all of those diagnoses valid? New researc...
FEB 24, 2020
Health & Medicine
FEB 24, 2020
Breast Cancer Screening, without the Radiation
Researchers from the University of Waterloo have developed a prototype of a novel technology that is capable of screening for breast cancer without using r...
FEB 24, 2020
Drug Discovery & Development
FEB 24, 2020
Leukemic Drugs May Target Lung Cancer
Two approved therapeutics for treating leukemia are currently being investigated for treatment-resistant lung cancer.  The findings were based on a li...
Loading Comments...